| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1110532001 |
| P356 | DOI | 10.1038/S41433-018-0304-Z |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/s41433-018-0304-z |
| P932 | PMC publication ID | 6367394 |
| P698 | PubMed publication ID | 30538310 |
| P50 | author | Tilak Das | Q55113890 |
| P2093 | author name string | Andrew J Patterson | |
| Martin J Graves | |||
| Jonathan C P Roos | |||
| Rachna Murthy | |||
| P2860 | cites work | Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience | Q31012328 |
| Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach | Q33647383 | ||
| Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score. | Q34369480 | ||
| Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. | Q34394088 | ||
| Teprotumumab for Thyroid-Associated Ophthalmopathy. | Q34556184 | ||
| Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments. | Q35154018 | ||
| Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation | Q35316130 | ||
| Signal intensity and T2 time of extraocular muscles in assessment of their physiological status in MR imaging in healthy subjects | Q36487148 | ||
| Radiologic measurement of extraocular muscle volumes in patients with Graves' orbitopathy: a review and guideline | Q36497512 | ||
| Quantification of liver fat with magnetic resonance imaging | Q37811338 | ||
| Evaluating the Microcirculation of Normal Extraocular Muscles Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging | Q38765259 | ||
| Lymphoma and inflammation in the orbit: Diagnostic performance with diffusion-weighted imaging and dynamic contrast-enhanced MRI. | Q38959737 | ||
| MRI in Graves orbitopathy: recognition of enlarged muscles and prediction of steroid response | Q41002632 | ||
| Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy | Q45234915 | ||
| Orbital Fat Volumetry and Water Fraction Measurements Using T2-Weighted FSE-IDEAL Imaging in Patients with Thyroid-Associated Orbitopathy. | Q48179202 | ||
| Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: An initial observational cohort study. | Q50106668 | ||
| Novel thermal imaging analysis technique for detecting inflammation in thyroid eye disease. | Q51035816 | ||
| Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity. | Q53184848 | ||
| The value of the short tau inversion recovery sequence in magnetic resonance imaging of thyroid eye disease. | Q53894020 | ||
| Transcriptome Analysis of Orbital Adipose Tissue in Active Thyroid Eye Disease Using Next Generation RNA Sequencing Technology. | Q55016513 | ||
| The measurement of change in Graves' ophthalmopathy. | Q55067661 | ||
| Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy | Q58606862 | ||
| Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg | Q60332531 | ||
| Modification of the Classification of the Eye Changes of Graves' Disease: Recommendations of the Ad Hoc Committee of The American Thyroid Association | Q67020629 | ||
| Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements | Q72260946 | ||
| Quantitative CT of the orbit in Graves' disease | Q73331482 | ||
| Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease | Q74192624 | ||
| Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease | Q81752092 | ||
| Imaging of inflammation in Graves' ophthalmopathy by positron emission tomography/computed tomography | Q83218293 | ||
| Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment | Q87366046 | ||
| Grading Severity and Activity in Thyroid Eye Disease | Q89310896 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 235-243 | |
| P577 | publication date | 2019-02-01 | |
| P1433 | published in | Eye | Q10278937 |
| P1476 | title | T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study | |
| P478 | volume | 33 |
| Q94461775 | A quantitative method to assess muscle edema using short TI inversion recovery MRI |
| Q101166513 | Clinical features and clinical course of thyroid-associated ophthalmopathy: a case series of 3620 Chinese cases |
| Q101564235 | Histogram analysis of T2 mapping for detecting early involvement of extraocular muscles in patients with thyroid-associated ophthalmopathy |
| Q91521030 | Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves' orbitopathy |
Search more.